Back to WA Weiss Asset Management LP
TBPH
Showing 8 of 20 quarters
Position history for WAWeiss Asset Management LP's holdings in THERAVANCE BIOPHARMA INC
As of its Q2 2026 13F, Weiss Asset Management held 7,457,060 shares of TBPH (Theravance Biopharma), worth $126.8M. Weiss Asset Management's 13F filings listed TBPH from Q4 2021 to Q2 2026, 19 quarterly filings. TBPH was 1.3% of Weiss Asset Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$70.2M
Total Shares Change
-7.5M
Quarter-by-Quarter History